Dr. Ko is an Assistant Professor of Medicine at Boston University School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women’s Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.
- Member, BU-BMC Cancer Center, Boston University
- Member, Center of Excellence in Women’s Health, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Johns Hopkins University School of Medicine, MD
- Johns Hopkins University School of Public Health, MPH
- Harvard University, AM
- Barnard College, BA
- Published on 7/9/2021
Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Jul 09. PMID: 34241741.
- Published on 3/1/2021
Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. JAMA Oncol. 2021 Mar 01; 7(3):370-378. PMID: 33475714.
- Published on 2/23/2021
Chen K, Abbassi M, Ko NY. A Shock-Like Pain and Inability to Ambulate: Thoracic Spinal Cord Compression from Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jan-Apr; 14(1):56-61. PMID: 33776682.
- Published on 1/15/2021
Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. PMID: 33449809.
- Published on 1/1/2021
Poulson MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, Ko NY, Sachs TE, Cassidy MR. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Ann Surg. 2021 01 01; 273(1):3-9. PMID: 32889878.
- Published on 12/8/2020
Gupta VK, Dennis M, Mann E, Jacobson JO, Ko NY. Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO Oncol Pract. 2021 03; 17(3):e454-e460. PMID: 33290161.
- Published on 12/1/2020
Oladeru OT, Hirsch AE, Ko NY. Trends in Deescalation of Localized Breast Cancer Treatment and Caution for the Most Vulnerable Patients-A Look Back on the Decade That Was. JAMA Oncol. 2020 Dec 01; 6(12):1863-1864. PMID: 32970115.
- Published on 12/1/2020
Lombardi FL, Jafari N, Bertrand KA, Oshry LJ, Cassidy MR, Ko NY, Denis GV. Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte. 2020 12; 9(1):313-325. PMID: 32633194.
- Published on 9/4/2020
Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Dec; 184(3):849-859. PMID: 32888137.
- Published on 8/20/2020
Mukand NH, Zolekar A, Ko NY, Calip GS. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2220-2229. PMID: 32856609.
View 38 more publications: View full profile at BUMC